{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:16:11Z","timestamp":1788970571709,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.molmed.2026.07.001","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:19:28Z","timestamp":1784607568000},"page":"837-839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Keratin 16 puts the brakes on type I interferon signalling"],"prefix":"10.1016","volume":"32","author":[{"given":"Syed F.H.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine Y.","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4084-4836","authenticated-orcid":false,"given":"Edel A.","family":"O\u2019Toole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2026.07.001_bb0005","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/bjd\/ljaf054","article-title":"Palmoplantar epidermal differentiation disorders: a new classification toward pathogenesis-based therapy","volume":"193","author":"Sprecher","year":"2025","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.molmed.2026.07.001_bb0010","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adx9123","article-title":"Keratin 16 inhibits type I interferon responses in differentiating keratinocytes of stressed and diseased skin","volume":"18","author":"Cohen","year":"2026","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2026.07.001_bb0015","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.chom.2012.04.006","article-title":"The mitochondrial targeting chaperone 14-3-3\u03b5 regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity","volume":"11","author":"Liu","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.molmed.2026.07.001_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002779","article-title":"Repeated stress to the skin amplifies neutrophil infiltration in a keratin 17- and PKC\u03b1-dependent manner","volume":"22","author":"Xu","year":"2024","journal-title":"PLoS Biol."},{"key":"10.1016\/j.molmed.2026.07.001_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2023.102236","article-title":"A keratin code defines the textile nature of epithelial tissue architecture","volume":"85","author":"Di Russo","year":"2023","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.molmed.2026.07.001_bb0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13046-019-1091-5","article-title":"A novel miR-365-3p\/EHF\/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing \u03b25-integrin\/c-met signaling pathway","volume":"38","author":"Huang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2026.07.001_bb0035","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/cancers17081279","article-title":"Cancer cell-intrinsic type I interferon signaling promotes antitumor immunity in head and neck squamous cell carcinoma","volume":"17","author":"Xie","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.molmed.2026.07.001_bb0040","first-page":"1385","article-title":"JAK inhibitors and black box warnings: what is the future for JAK inhibitors? Expert Rev","volume":"19","author":"Tokareva","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.molmed.2026.07.001_bb0045","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/bjd.18794","article-title":"Revisiting pachyonychia congenita: a case-cohort study of 815 patients","volume":"182","author":"Samuelov","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.molmed.2026.07.001_bb0050","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.jid.2026.01.011","article-title":"Proteomics reveals altered lipid biosynthesis and keratin hyperphosphorylation in pachyonychia congenita","volume":"146","author":"Ceccacci","year":"2026","journal-title":"J. Invest. Dermatol."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491426001711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491426001711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:43:38Z","timestamp":1788968618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491426001711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1471491426001711"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2026.07.001","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Keratin 16 puts the brakes on type I interferon signalling","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2026.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}